94 related articles for article (PubMed ID: 21720262)
1. Urocortin 2 sustains haemodynamic and renal function during introduction of beta-blockade in experimental heart failure.
Rademaker MT; Charles CJ; Nicholls G; Richards M
J Hypertens; 2011 Sep; 29(9):1787-95. PubMed ID: 21720262
[TBL] [Abstract][Full Text] [Related]
2. Urocortin 2 inhibits furosemide-induced activation of renin and enhances renal function and diuretic responsiveness in experimental heart failure.
Rademaker MT; Charles CJ; Nicholls MG; Richards AM
Circ Heart Fail; 2009 Nov; 2(6):532-40. PubMed ID: 19919977
[TBL] [Abstract][Full Text] [Related]
3. Urocortin 2 combined with angiotensin-converting enzyme inhibition in experimental heart failure.
Rademaker MT; Charles CJ; Nicholls MG; Richards AM
Clin Sci (Lond); 2008 May; 114(10):635-42. PubMed ID: 18052934
[TBL] [Abstract][Full Text] [Related]
4. Integrated hemodynamic, hormonal, and renal actions of urocortin 2 in normal and paced sheep: beneficial effects in heart failure.
Rademaker MT; Cameron VA; Charles CJ; Richards AM
Circulation; 2005 Dec; 112(23):3624-32. PubMed ID: 16330704
[TBL] [Abstract][Full Text] [Related]
5. Interactions of enhanced urocortin 2 and mineralocorticoid receptor antagonism in experimental heart failure.
Rademaker MT; Charles CJ; Nicholls MG; Richards AM
Circ Heart Fail; 2013 Jul; 6(4):825-32. PubMed ID: 23753530
[TBL] [Abstract][Full Text] [Related]
6. Urocortin 2 protects heart and kidney structure and function in an ovine model of acute decompensated heart failure: Comparison with dobutamine.
Rademaker MT; Ellmers LJ; Charles CJ; Mark Richards A
Int J Cardiol; 2015 Oct; 197():56-65. PubMed ID: 26113475
[TBL] [Abstract][Full Text] [Related]
7. Combined angiotensin-converting enzyme inhibition and adrenomedullin in an ovine model of heart failure.
Rademaker MT; Charles CJ; Cooper GJ; Coy DH; Espiner EA; Lewis LK; Nicholls MG; Richards AM
Clin Sci (Lond); 2002 Jun; 102(6):653-60. PubMed ID: 12049620
[TBL] [Abstract][Full Text] [Related]
8. Urocortin 3: haemodynamic, hormonal, and renal effects in experimental heart failure.
Rademaker MT; Cameron VA; Charles CJ; Richards AM
Eur Heart J; 2006 Sep; 27(17):2088-98. PubMed ID: 16825287
[TBL] [Abstract][Full Text] [Related]
9. Urocortin 2 infusion in human heart failure.
Davis ME; Pemberton CJ; Yandle TG; Fisher SF; Lainchbury JG; Frampton CM; Rademaker MT; Richards M
Eur Heart J; 2007 Nov; 28(21):2589-97. PubMed ID: 17720993
[TBL] [Abstract][Full Text] [Related]
10. Four-day urocortin-I administration has sustained beneficial haemodynamic, hormonal, and renal effects in experimental heart failure.
Rademaker MT; Charles CJ; Espiner EA; Frampton CM; Lainchbury JG; Richards AM
Eur Heart J; 2005 Oct; 26(19):2055-62. PubMed ID: 15961410
[TBL] [Abstract][Full Text] [Related]
11. Hemodynamic, hormonal, and renal actions of adrenomedullin 2 in experimental heart failure.
Rademaker MT; Charles CJ; Nicholls MG; Richards AM
Circ Heart Fail; 2008 Jul; 1(2):134-42. PubMed ID: 19808282
[TBL] [Abstract][Full Text] [Related]
12. Urocortin 2 induces potent long-lasting inhibition of cardiac sympathetic drive despite baroreflex activation in conscious sheep.
Charles CJ; Jardine DL; Rademaker MT; Richards AM
J Endocrinol; 2010 Feb; 204(2):181-9. PubMed ID: 19914944
[TBL] [Abstract][Full Text] [Related]
13. Prolonged urocortin 2 administration in experimental heart failure: sustained hemodynamic, endocrine, and renal effects.
Rademaker MT; Charles CJ; Ellmers LJ; Lewis LK; Nicholls MG; Richards AM
Hypertension; 2011 Jun; 57(6):1136-44. PubMed ID: 21536988
[TBL] [Abstract][Full Text] [Related]
14. Endogenous urocortins reduce vascular tone and renin-aldosterone/endothelin activity in experimental heart failure.
Rademaker MT; Charles CJ; Espiner EA; Frampton CM; Lainchbury JG; Richards AM
Eur Heart J; 2005 Oct; 26(19):2046-54. PubMed ID: 15821006
[TBL] [Abstract][Full Text] [Related]
15. Safety and efficacy of beta blockade in patients with chronic congestive heart failure awaiting transplantation.
Kalman J; Buchholz C; Steinmetz M; Courtney M; Gass A; Lansman S; Kukin ML
J Heart Lung Transplant; 1995; 14(6 Pt 1):1212-7. PubMed ID: 8719469
[TBL] [Abstract][Full Text] [Related]
16. [Recombinant human brain natriuretic peptide on the cardiac hemodynamics and renal function in dogs with heart failure].
Xu XW; Zeng GY; Yang Y; Liu HX
Yao Xue Xue Bao; 2002 Oct; 37(10):758-62. PubMed ID: 12567856
[TBL] [Abstract][Full Text] [Related]
17. Beneficial hemodynamic, endocrine, and renal effects of urocortin in experimental heart failure: comparison with normal sheep.
Rademaker MT; Charles CJ; Espiner EA; Fisher S; Frampton CM; Kirkpatrick CM; Lainchbury JG; Nicholls MG; Richards AM; Vale WW
J Am Coll Cardiol; 2002 Oct; 40(8):1495-505. PubMed ID: 12392842
[TBL] [Abstract][Full Text] [Related]
18. Direct cardiac and vascular actions of adrenomedullin in conscious sheep.
Parkes DG; May CN
Br J Pharmacol; 1997 Mar; 120(6):1179-85. PubMed ID: 9134233
[TBL] [Abstract][Full Text] [Related]
19. Urocortin-2 infusion in acute decompensated heart failure: findings from the UNICORN study (urocortin-2 in the treatment of acute heart failure as an adjunct over conventional therapy).
Chan WY; Frampton CM; Crozier IG; Troughton RW; Richards AM
JACC Heart Fail; 2013 Oct; 1(5):433-41. PubMed ID: 24621976
[TBL] [Abstract][Full Text] [Related]
20. [The effects of combined beta(1) adrenergic receptor antagonist and beta(2) adrenergic receptor agonist therapy on cardiac function and myocardial apoptosis in heart failure rats].
Li WM; Gan RT; Wang X; Wu S; Shen JX; Xiu CH
Zhonghua Xin Xue Guan Bing Za Zhi; 2007 Jul; 35(7):615-9. PubMed ID: 17961425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
